SR-17018 was formulated to be a G-protein-biased MOP agonist, but exhibits a variety of pharmacological outcomes which cannot be stated with the biased signaling hypothesis.The synthesis of SR17018 involves quite a few intricate steps that use a variety of chemical reactions. A detailed analysis reveals which the compound's synthesis starts off fro